Global Doxorubicin Market Size, Share, Forecast Report, 2020-2027

The global doxorubicin market accounts for USD 916.5 million in 2017 and expected to register steady growth rate of 6.5% during the forecast period.

The market for doxorubicin is growing at steady pace. The various factors influencing the growth of the market include; increasing geriatric population and with-it growing prevalence of cancer cases and increasing awareness programs for cancer treatment are responsible for driving the growth of the market. In 2017, according to the Canadian Cancer Society it was estimated that around 206,200 new cases of cancer and 80,800 deaths were occurred in Canada due to cancer. Additionally, in 2016 according to the Office for National Statistics reported that over 303,135 cancers registered that is equal to 828 new cases were diagnosed each day during 2016.

The growing adoption for minimally invasive surgical procedures, large presence of surgical and ablation centers, and technological advancements are contributing to the rising demand for ablation technologies.

The cost suppression measures adopted by different governments, stringent regulatory authorities, and various side effects of doxorubicin are hampering the growth of the market during the forecast period.

Segmentation

The global doxorubicin market has been segmented on the basis of application, and distribution channel.

The application segment is divided into liver cancer, gastric cancer, breast cancer, bone sarcoma, prostate cancer, stomach cancer, ovarian cancer, leukemia and others.

The market, by distribution channel, has been segmented into hospital pharmacy, retail pharmacy and others.

Global Doxorubicin Market, by Application

• Liver cancer
• Gastric cancer
• Breast cancer
• Bone sarcoma
• Prostate cancer
• Stomach Cancer
• Ovarian cancer
• Leukemia
• others

Global Doxorubicin Market, by Distribution Channel

• Hospital pharmacy
• Retail pharmacy
• Others

Global Doxorubicin Market, by Region

• Americas
  • North America
    • US
    • Canada
  • South America
• Europe
  • Western Europe
    • Germany
    • France
    • Italy
    • Spain
    • UK
    • Rest of Western Europe
  • Eastern Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• The Middle East & Africa
  • Middle East
  • Africa

Company Profiles    

• Pfizer, Inc
• Sun Pharmaceutical Industries Ltd.
• Janssen Pharmaceuticals
• Accord Healthcare
• Novartis AG
• Sandoz
• Reddy’s Laboratories Ltd.
• Teva Pharmaceuticals
• GLENMARK PHARMACEUTICALS LTD.